Retinol-Binding Protein (RBP) assays, for serum and urine, for Optilite®, IMMAGE® and other Clinical Chemistry analyzers
TRIMERO Diagnostics offers IVD CE marked Retinol Binding Protein (RBP, RBP4) assays, for serum and urine samples.
Specifically developed kits are available for Optilite® Clinical Chemistry analyzers and Beckman Coulter’s IMMAGE® Immunochemical Systems.
RBP turbidimetric kits are also available for their use in the most popular Clinical Chemistry analyzers.
CHARACTERISTICS and PERFORMANCE of the Assays:
- Method: Particle-Enhanced Immunoprecipitation (Turbidimetry/Nephelometry)
- Initial Measuring Range – Serum: 5 – 120 mg/L
- Initial Measuring Range – Urine: 0.01 – 1 mg/L
- LoQ – Serum: Less than 5 mg/L
- LoQ – Urine: Less than 0.03 mg/L
- Repeatibility: CV < 3%, for both serum and urine
- Within-Lab Precision: CV < 3%, for both serum and urine
- Method Comparison: Bias <10% (comparative method: nephelometry)
- Proven assays, on the market since 2016
The particle-enhanced reaction determines a very good sensitivity for the assays allowing the measurement of the extremely low urinary levels and results in excellent method performance.
Other TRIMERO’s assays available for nephelometry and turbidimetry include:
KLoneus® Free Light Chains (FLC) for serum and urine, Serum Amyloid A, C1q Complement, C5 Complement, Factor B (C3 Proactivator), C1 (Esterase) Inhibitor, IgD Immunoglobulins, Soluble Transferrin Receptor (sTfR), Hemopexin, Cystatin-C for serum and urine, A1-Microglobulin, Beta-2 Microglobulin for serum and urine, Kappa and Lambda Light Chains for serum and urine.
Optilite® is a registered trademark of The Binding Site Group Limited, Birmingham, UK.
IMMAGE® is a registered trademark of Beckman Coulter, Inc., Fullerton, CA.
